title: [Prevalence of male breast cancer in our department during a 5-year period].
abstract: Male breast cancer is a rare entity. Statistics suggest the female:male ratio is100:1. Male breast cancer is most frequent in elderly patients, but it can occur at any age. The mean age of the onset of the disease is 10 years later in males compared to female patients. Here, the authors review the predisposing factors, main types of male breast cancer, diagnosis and treatment principals. Furthermore, they summarise data of five patients from their practice as regards diagnostic work-up, surgical and adjuvant treatments.
authors.affiliation: BAZ Megyei Kórház és Egyetemi Oktató Kórház Általános Sebészet 3531 Miskolc Szentpéteri kapu. 72-76. cskbt@chello.hu
authors.forename: Imre
authors.initials: I
authors.lastname: Cseh
authors.forename: Mária
authors.initials: M
authors.lastname: Kerekes
authors.forename: Tibor
authors.initials: T
authors.lastname: Solymosi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018567:Breast Neoplasms, Male / Q000737:chemistry / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000628:therapy; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007150:Immunohistochemistry; D008297:Male; D008408:Mastectomy; D008875:Middle Aged; D015995:Prevalence; D018714:Radiotherapy, Adjuvant; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human